Technoderma Medicines, Inc. ("the Company"), a clinical stage biopharmaceutical company, is pleased to report the Company has completed its Phase 2a clinical trial (NCT06363461) of topical TDM-180935 ...
Artificial Intelligence (AI) can be a great tool in diagnosing and management of atopic dermatitis -- a chronic skin condition -- leading to more accurate, early, and standardised identification ...
New data reveals that longer-term lebrikizumab treatment significantly improves outcomes for patients with moderate-to-severe atopic dermatitis who didn’t meet response criteria by week 16.